• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何比较老年血友病患者与普通人群的心血管疾病及风险因素。

How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population.

作者信息

Berger K, Schopohl D, Lowe G, Holme P A, Tait R C, Combescure C, Rauchensteiner S, Klamroth R

机构信息

Department of Haematology/Oncology, University Hospital of Munich, Munich, Germany.

Haemophilia Centre, Glasgow, UK.

出版信息

Haemophilia. 2016 Sep;22(5):e406-16. doi: 10.1111/hae.13069.

DOI:10.1111/hae.13069
PMID:27650262
Abstract

INTRODUCTION

Studies on the prevalence of cardiovascular disease (CVD) and risk factors in patients with haemophilia (PWH) in comparison to the general population have generated inconsistent results. The ADVANCE Working Group collected data on CV comorbidities in PWH aged ≥40 years (H(3) Study).

AIM

Identification of German epidemiological data on CVD for the general population, evaluation for appropriateness, and execution of comparisons with PWH.

METHODS

Identification of data sources by structured literature (EMBASE, MEDLINE) searches.

INCLUSION CRITERIA

German general population, CVD and risk factors, gender/age stratification, sample size >500 male persons, age groups ≥40 years, current data collection, language English/German. Comparison of data on CVD and risk factors in PWH (H(3)  Study) with published German general population data.

RESULTS

Criteria for data source appropriateness were defined. Of five national and three international epidemiological studies, the DEGS1 Study (German Health Interview and Examination Survey for Adults) was identified as the most suitable comparator. Compared with men from DEGS1, hypertension was significantly more prevalent in PWH aged 50-59 years (41.7% [95% CI: 37.3-46.2] vs. 52.0% [95% CI: 43.7-60.1], P = 0.03). Coronary artery/heart disease (CHD) was significantly less prevalent in PWH aged ≥60 years (60-69 years: 19.5% [95% CI: 15.9-23.7] vs. 8.1% [95% CI: 3.3-16.1], P = 0.02; 70-79 years: 30.5% [95% CI: 25.9-35.5] vs. 11.8% [95% CI: 5.2-21.9], P = 0.002). No statistically significant difference for ischaemic cerebrovascular disease/stroke was detected.

CONCLUSION

Increased prevalence of hypertension in PWH should trigger regular screening. CHD does occur in PWH aged ≥60 years though apparently with lower prevalence. Given the growing population of elderly PWH, guidelines for prevention and treatment of CVD should be developed.

摘要

引言

与普通人群相比,关于血友病患者(PWH)心血管疾病(CVD)患病率及其风险因素的研究结果并不一致。ADVANCE工作组收集了年龄≥40岁的PWH的心血管合并症数据(H(3)研究)。

目的

确定德国普通人群心血管疾病的流行病学数据,评估其适用性,并与PWH的数据进行比较。

方法

通过结构化文献检索(EMBASE、MEDLINE)确定数据来源。

纳入标准

德国普通人群、心血管疾病及其风险因素、性别/年龄分层、样本量>500名男性、年龄组≥40岁、当前数据收集、语言为英语/德语。将PWH的心血管疾病及其风险因素的数据(H(3)研究)与已发表的德国普通人群数据进行比较。

结果

定义了数据来源适用性的标准。在五项国内和三项国际流行病学研究中,DEGS1研究(德国成人健康访谈和检查调查)被确定为最合适的比较对象。与DEGS1研究中的男性相比,50 - 59岁的PWH中高血压患病率显著更高(41.7% [95%置信区间:37.3 - 46.2] 对 52.0% [95%置信区间:43.7 - 60.1],P = 0.03)。≥60岁的PWH中冠状动脉/心脏病(CHD)患病率显著更低(60 - 69岁:19.5% [95%置信区间:15.9 - 23.7] 对 8.1% [95%置信区间:3.3 - 16.1],P = 0.02;70 - 79岁:30.5% [95%置信区间:25.9 - 35.5] 对 11.8% [95%置信区间:5.2 - 21.9],P = 0.002)。未检测到缺血性脑血管疾病/中风的统计学显著差异。

结论

PWH中高血压患病率的增加应促使进行定期筛查。≥60岁的PWH中确实会发生CHD,尽管患病率明显较低。鉴于老年PWH人群不断增加,应制定心血管疾病的预防和治疗指南。

相似文献

1
How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population.如何比较老年血友病患者与普通人群的心血管疾病及风险因素。
Haemophilia. 2016 Sep;22(5):e406-16. doi: 10.1111/hae.13069.
2
Cardiovascular disease (CVD) in Canadians with haemophilia: Age-Related CVD in Haemophilia Epidemiological Research (ARCHER study).加拿大血友病患者的心血管疾病(CVD):血友病流行病学研究中的年龄相关性心血管疾病(ARCHER研究)。
Haemophilia. 2015 Nov;21(6):736-41. doi: 10.1111/hae.12768. Epub 2015 Jul 29.
3
Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).血友病患者心血管疾病(CVD)事件的患病率和危险因素:美国(US)单一家血有病治疗中心的经验。
Haemophilia. 2011 Jul;17(4):597-604. doi: 10.1111/j.1365-2516.2010.02463.x. Epub 2011 Feb 15.
4
Prevalence and risk factors of atherothrombotic events among 1054 hemophilia patients: a population-based analysis.1054 例血友病患者的动脉血栓栓塞事件的流行率和危险因素:基于人群的分析。
Thromb Res. 2015 Mar;135(3):502-7. doi: 10.1016/j.thromres.2014.12.027. Epub 2015 Jan 10.
5
Clinical management of older persons with haemophilia.老年人血友病的临床管理。
Crit Rev Oncol Hematol. 2014 Feb;89(2):197-206. doi: 10.1016/j.critrevonc.2013.07.005. Epub 2013 Aug 13.
6
Risk assessment for coronary heart disease in patients with haemophilia: a single centre study in the United States.血友病患者冠心病的风险评估:美国一项单中心研究
Haemophilia. 2014 Nov;20(6):763-70. doi: 10.1111/hae.12472. Epub 2014 Jun 3.
7
Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.缺血性事件较为罕见,且日本成年血友病患者的高血压患病率并不高:亚洲的首次多中心研究。
Haemophilia. 2019 Jul;25(4):e223-e230. doi: 10.1111/hae.13749. Epub 2019 May 2.
8
Cardiovascular disease prevalence and relevance in haemophilia: a scoping review.血友病患者中心血管疾病的患病率和相关性:一项范围综述。
Haemophilia. 2015 May;21(3):e156-e166. doi: 10.1111/hae.12596. Epub 2014 Nov 24.
9
Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics.血友病患者体验、结果和机遇(HERO)研究:调查方法学和人口统计学。
Haemophilia. 2014 Jan;20(1):44-51. doi: 10.1111/hae.12239. Epub 2013 Aug 1.
10
Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B.成人 A 型或 B 型血友病患者脑微出血的患病率及相关危险因素。
Haemophilia. 2018 Mar;24(2):271-277. doi: 10.1111/hae.13398. Epub 2017 Dec 28.

引用本文的文献

1
In vitro evaluation of global coagulation potential of emicizumab and warfarin using rotational thromboelastometry.使用旋转血栓弹力图对艾美赛珠单抗和华法林的整体凝血潜力进行体外评估。
Int J Hematol. 2025 Apr 28. doi: 10.1007/s12185-025-03986-2.
2
Thrombin generation to evaluate the complex hemostatic balance of hemophilia A plasma containing direct oral anticoagulant and supplemented by factor VIII.通过凝血酶生成来评估含直接口服抗凝剂且补充了凝血因子 VIII 的甲型血友病血浆的复杂止血平衡。
Res Pract Thromb Haemost. 2024 Sep 23;8(7):102576. doi: 10.1016/j.rpth.2024.102576. eCollection 2024 Oct.
3
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: analysis from the PROTECT VIII study.
达莫妥珠单抗α聚乙二醇预防治疗对年龄≥40岁的重度甲型血友病合并症患者的疗效与安全性:来自PROTECT VIII研究的分析
Ther Adv Hematol. 2023 Apr 22;14:20406207231166779. doi: 10.1177/20406207231166779. eCollection 2023.
4
Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review.血友病患者与普通人群中特定出血和血栓形成事件的患病率:一项范围综述。
Res Pract Thromb Haemost. 2022 Dec 9;7(1):100007. doi: 10.1016/j.rpth.2022.100007. eCollection 2023 Jan.
5
Cardiovascular Risk Factors in Patients with Congenital Hemophilia: A Focus on Hypertension.先天性血友病患者的心血管危险因素:聚焦高血压
Diagnostics (Basel). 2022 Nov 24;12(12):2937. doi: 10.3390/diagnostics12122937.
6
Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry.血友病患者颅内出血仍是一个未解决的问题:意大利EMO.REC注册研究的最终结果
J Clin Med. 2022 Apr 1;11(7):1969. doi: 10.3390/jcm11071969.
7
BAY 81-8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years.BAY 81-8973 在 LEOPOLD I 扩展研究中,在≤2 年的时间内,展示了在重度 A 型血友病患者中的疗效、安全性和关节状态改善。
Eur J Haematol. 2020 Jun;104(6):594-601. doi: 10.1111/ejh.13402. Epub 2020 Mar 23.
8
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry.联合使用抗纤维蛋白溶解药物和活化的凝血酶原复合物浓缩物(aPCC)与获得性血友病 A 患者的血栓栓塞事件无关:FAIR 登记处的数据。
J Thromb Thrombolysis. 2019 Jan;47(1):129-133. doi: 10.1007/s11239-018-1750-y.
9
Current concepts in the management of stable ischemic heart disease and acute coronary syndrome in patients with hemophilia.血友病患者稳定型缺血性心脏病和急性冠状动脉综合征管理的当前概念
Ann Transl Med. 2018 Aug;6(15):299. doi: 10.21037/atm.2018.05.29.